این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
سه شنبه 25 آذر 1404
Journal of Research in Medical Sciences
، جلد ۲۱، شماره ۱۲، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Assessment of the role of plasma nitric oxide levels, T?786C genetic polymorphism, and gene expression levels of endothelial nitric oxide synthase in the development of coronary artery disease
چکیده انگلیسی مقاله
Background: Reduced bioavailability of nitric oxide (NO) and the T?786C polymorphism of endothelial nitric oxide synthase (eNOS) gene have been reported as risk factors for the development of coronary artery disease (CAD) with conflicting results. We investigated the association of plasma NO levels, T?786C genetic polymorphism, and gene expression levels of eNOS with CAD risk in an Iranian subpopulation. Materials and Methods: Studied population included 100 patients with angiographically verified CAD and 100 ethnically matched controls. Analysis of T?786C genetic polymorphism and gene expression levels of eNOS was conducted by polymerase chain reaction (PCR) restriction fragment length polymorphism and real?time reverse transcription?PCR methods, respectively. Plasma levels of NO were measured using Griess method. Results: The CC genotype distribution (15% vs. 6%, P = 0.011) and minor C allele frequency (36.5% vs. 21.5%, P = 0.001) of eNOS T?786C polymorphism differed significantly between CAD patients and control. Furthermore, eNOS T?786C polymorphism was more common among smoker than nonsmoker CAD patients (27.7% vs. 7.8%, P = 0.044). The association of the eNOS T?786C polymorphism with the severity of CAD (number of diseased vessel) was significant ( P < 0.05). The gene expression levels of eNOS were significantly lower in the heterozygote (0.49 ± 0.1, P = 0.023) and mutant homozygote (0.36 ± 0.09, P = 0.011) genotypes than that of wild?type genotype ( P < 0.05). In addition, NO levels were significantly lower in CAD patients compared with control subjects (42.62 ± 12.26 vs. 55.48 ± 16.57, P = 0.002) and showed intergenotypic variation in the CAD patients. Conclusion: Our study indicated that reduced NO levels and eNOS T?786C genetic polymorphism are significant risk factors for the development and severity of CAD in the Iranian population.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
خلیل محمودی | khalil mahmoudi
محمد سلیمان سلطانپور | mohamad soleyman soltan pour
کورش کمالی | kourosh kamali
نشانی اینترنتی
http://jrms.mui.ac.ir/index.php/jrms/article/view/10618
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/218/article-218-316447.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات